As we know, the vaccine stocks are limited and all (vaccine producers) are attempting to accelerate production.
Jakarta – The government’s strategy of immunizing 181.5 million Indonesians against the coronavirus hinges on the availability of vaccines, spokesperson for the COVID-19 Managing Job Force, Prof. Wiku Adisasmito, said.
” As we know, the vaccine stocks are restricted and all (vaccine manufacturers) are trying to accelerate production,” he stated during an online conversation coming from here on Saturday.
In addition to minimal vaccine stocks, a mutation of the virus might also pose a danger to the administration of COVID-19 vaccines to individuals in the country, he observed.
The variety of individuals to be vaccinated is not in proportion to the availability of vaccines, he explained. Consequently, all countries, consisting of Indonesia, are taking on one another to get vaccines from providers, he said.
All sides can plan to immunize one million individuals daily, but they will discover it tough to realize the strategy, he added.
” Certain Indonesian areas, including Jakarta, can accomplish the target of vaccinating one million people in a day. Other regions will have troubles accomplishing the target due to geographical constraints,” he said.
The vaccination program might last longer or be faster than anticipated, he said.
To speed up the vaccination program, the existing vaccine stocks need to be enough for 181.5 million Indonesians, he explained.
The government has set a target of inoculating 181,554,464 individuals, or 70 percent of the total Indonesian population, with the aim of building herd resistance against the coronavirus.
Far, 1,017,186 Indonesian health care workers out of the targeted 1,468,764 have gotten COVID-19 vaccine shots, according to information supplied by the COVID-19 Managing Task Force on February 11, 2021.
Of the 1,017,186 health care employees who have actually received the first dose of the COVID-19 vaccine, 345,605 have been administered their second dose, too, it mentioned.
Everyone covered by the vaccine program will need to be administered two dosages of the COVID-19 vaccine. This implies that Indonesia will need 362 million dosages of the COVID-19 vaccine to inoculate 181 million people.
Up previously, Indonesia has actually gotten 28 million doses of the coronavirus vaccine from Sinovac.
It has actually bought COVID-19 vaccines from various sources: 125 million dosages from China’s Sinovac Biotech Ltd; 100 million dosages from US-Canada’s Novavax; 100 million doses from British AstraZeneca; 100 million doses from Germany-US Pfizer vaccine; and, 16-100 million dosages of complimentary vaccines from the GAVI COVAX Facility, as part of a multilateral cooperation collaborated by the WHO.
In addition, the nation is likewise developing its native vaccine, called Red and White after the nationwide flag.
Related news: Indonesia steps up war against COVID-19
Related news: COVID-19: Authorities prepare 13,500 vaccinators, 40,336 contact-tracers
